Secretary Kathleen Sebelius said:
“The technology has advanced in recent years to a point that we believe it could help meet a surge in demand for U.S.-based vaccine for seasonal and pandemic flu. We want to use the technology to help our nation respond to emerging infectious diseases.”
Read the full story here.
To connect with more professionals in the Vaccines field, join our Vaccines Development Forum Group on LinkedIn or join us in Boston September 23-25 for the Vaccines Development Forum.
Share this article with your social network, just click below to share now!
|
|
No comments :
Post a Comment